ReviewNeurosurgical review2026
Trends in mortality and disability-adjusted life years (DALYs) attributable to subarachnoid hemorrhage in South Asia (2000-2023).
Review in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to analyze two-decade trends in mortality and disability-adjusted life years (DALYs) attributable to subarachnoid hemorrhage (SAH) across South Asian countries, highlighting regional and gender disparities and informing strategies for stroke prevention and care. Ecological trend analysis using publicly available population-level data from the Global Burden of Disease (GBD) database for the years 2000-2023.Population-level data for five South Asian countries: India, Pakistan, Bangladesh, Nepal, and Bhutan. Age-standardized mortality rates and DALYs per 100,000 population attributable to SAH. DALYs were further stratified into years of life lost (YLLs) and years lived with disability (YLDs). Gender-specific trends and country-level variations were assessed. Between 2000 and 2023, age-standardized rates for SAH showed significant variation in South Asian countries with increasing from 3.2 per 100,000 in 2000 to 4.2 per 100,000 in 2023, marking a 29.5% rise and an average annual percent change of 1.2% (95%CI:1.0-1.4). However, due to population growth and aging, absolute number of SAH related deaths increase from 26,951 to 65,635 deaths. India recorded the highest age-standardized mortality rate (36.1%) and absolute deaths (20,645 to 51,767), followed by Pakistan (25.3%). Bangladesh on the contrary showed a slight decline to 5.6 per 100,000 in 2023. DALY rates increased by 23.9% from 110.4 to 136.8 per 100,000, with an average annual percent change of 0.9% (95%CI:0.7-1.1). India and Pakistan experienced the most significant increases in absolute DALYs (India 851,404 to over 1.8 million and Pakistan 115,227 to 250,736). DALY rate in South Asia increased from 164.8 to 174.5 per 100,000) with average annual percent change of 0.3%. Our study showed both persistent growth and decreasing gender disparity in SAH related mortality and DALYs in South Asia. The age standardized mortality rate was 4.0 per 100,000 for females and 2.5 for males with an absolute difference of -1.5 and a relative difference of -37.2% in 2000. This remained high for females in 2023 at 4.6 and 3.7 for males showing a decrease in absolute difference of -0.8 and the relative difference to -18.0%. The risk factors that are contributing to SAH mortality in South Asia were hypertension, smoking, household air pollution due to solid fuel and body mass index. The burden of subarachnoid hemorrhage in South Asia has increased substantially, with rising age-standardized rates and a marked growth in absolute deaths and DALYs, particularly in India and Pakistan. Although gender disparities have narrowed over time, females continue to experience higher mortality rates than males. Targeted prevention addressing hypertension, smoking, household air pollution, and body mass index is urgently needed to reduce SAH burden in the region.
Indexed as
Identifiers
42249971What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.